HealthXL provides us the opportunity to make connections that will greatly aid in our capacity to improve patient care and bend the healthcare cost curve as the benefits of precision medicine are realized in the market.
Seattle, WA (PRWEB) July 26, 2017
YouScript is now a verified company with HealthXL, a global organization driving innovation in healthcare through an elite network of healthcare executives and global solutions. Companies can only obtain verified status when there is evidence that their product has a positive clinical or commercial impact. YouScript is a disruptive technology tackling the monumental adverse drug event crisis in the US today which claims a life every 5 minutes and causes billions of preventable healthcare costs.
YouScript’s CEO Kristine Ashcraft is part of the global advisory network to develop innovative and meaningful connections and solutions for some of healthcare’s biggest challenges. HealthXL created a network of incubation, live events, and a platform on equal ground from new ventures to established players in healthcare.
“Although our technology has been shown to reduce readmissions, ER visits, and deliver cost savings in as little as 60-days, YouScript’s challenge lies in reaching the right stakeholders in a complex system. HealthXL helps us reach thought leaders that are adopting solutions that help them meet the Triple Aim,” said Ashcraft. “I am very excited to join HealthXL and develop meaningful partnerships with these leaders in healthcare.”
Starting initially as an accelerator program, HealthXL connects payors, technology solution providers, device manufacturers, health providers, and other industry professionals with a platform to engage in information exchange. By utilizing this shared platform, companies can identify leaders, innovators, and investors.
HealthXL partners and key members:
- Cleveland Clinic
- Highmark Health
- Johnson & Johnson
Ashcraft is using the network to connect with key industry leaders to bring YouScript’s solutions to their problems, and finding new resources to solve challenges YouScript faces. “HealthXL provides us the opportunity to make connections that will greatly aid in our capacity to improve patient care and bend the healthcare cost curve as the benefits of precision medicine are realized in the market,” said Ashcraft.
Based on fifteen years of technology development that makes precision prescribing possible, Seattle-based YouScript was founded in 2016 after incubating the technology for over a decade at a leading pharmacogenetic testing lab. The YouScript clinical decision support tool is the only medication management system available that assesses the cumulative effect of a patient drug regimen and unique pharmacogenomic results. Based on over 14,000 curated references and product inserts, YouScript uses comprehensive predictive analytics to interpret and provide an at-a-glance summary of the complex web of genetics, medications, over-the-counters, herbals, and other factors impacting drug safety and response; identifying at risk patients for testing and offering ranked alternatives with reduced interaction risk whenever an adverse interaction risk is found.
For more information, visit: http://www.youscript.com